Sage Journals: Discover world-class research

Open access

Review article

First published 2020

Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer

Pernelle Lavaud, Clément Dumont, Constance Thibault [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2019

The Current Landscape of Treatment in Non-Metastatic Castration-Resistant Prostate Cancer

Joelle El-Amm, Jeanny B Aragon-Ching

Clinical Medicine Insights: Oncology

Free access

Research article

First published 2010-1

Elevated expression of the cytochrome b561,a neuroendocrine vesicle protein,in castration resistant prostate tumors

Anjali Srivastava, Spyro Mousses, Albert Dobi [...]

Cancer Biomarkers

Open access

Research article

First published 2022

GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)

Ciara Conduit, Blossom Mak, Wenjia Qu [...]

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2023-10

Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancer

Malvina Cremante, Silvia Puglisi, Annalice Gandini [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2022

Cabozantinib combination therapy for the treatment of solid tumors: a systematic review

Daniel Castellano, Andrea B. Apolo, Camillo Porta [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy;on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est)

Fabio Matrone, Luca Urso, Rossano Girometti [...]

Therapeutic Advances in Urology

Search results

Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer

The Current Landscape of Treatment in Non-Metastatic Castration-Resistant Prostate Cancer

Elevated expression of the cytochrome b561,a neuroendocrine vesicle protein,in castration resistant prostate tumors

GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)

Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancer

Cabozantinib combination therapy for the treatment of solid tumors: a systematic review

The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy;on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est)